Press Release Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease Read Press Release
Press Release Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab) Read Press Release
